MX2021004464A - Compuestos de tiazolida para el tratamiento de infecciones virales. - Google Patents

Compuestos de tiazolida para el tratamiento de infecciones virales.

Info

Publication number
MX2021004464A
MX2021004464A MX2021004464A MX2021004464A MX2021004464A MX 2021004464 A MX2021004464 A MX 2021004464A MX 2021004464 A MX2021004464 A MX 2021004464A MX 2021004464 A MX2021004464 A MX 2021004464A MX 2021004464 A MX2021004464 A MX 2021004464A
Authority
MX
Mexico
Prior art keywords
viral infections
treating viral
thiazolide compounds
thiazolide
compounds
Prior art date
Application number
MX2021004464A
Other languages
English (en)
Inventor
Maria Gabriella Santoro
Jean - Francois ROSSIGNOL
Original Assignee
Romark Laboratories Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romark Laboratories Lc filed Critical Romark Laboratories Lc
Publication of MX2021004464A publication Critical patent/MX2021004464A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

Los compuestos de tiazolida, tales como nitazoxanida y/o tizoxanida, pueden usarse contra los virus que pertenecen a la familia Picornaviridae o a la familia Paramyxoviridae.
MX2021004464A 2016-03-31 2018-09-28 Compuestos de tiazolida para el tratamiento de infecciones virales. MX2021004464A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662316463P 2016-03-31 2016-03-31

Publications (1)

Publication Number Publication Date
MX2021004464A true MX2021004464A (es) 2021-06-04

Family

ID=58530692

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021004464A MX2021004464A (es) 2016-03-31 2018-09-28 Compuestos de tiazolida para el tratamiento de infecciones virales.

Country Status (26)

Country Link
US (2) US11135202B2 (es)
EP (2) EP3677282A1 (es)
JP (2) JP6567781B2 (es)
KR (3) KR20210035339A (es)
CN (1) CN108289961A (es)
AU (2) AU2017244145B2 (es)
BR (1) BR112018069974A2 (es)
CA (2) CA3019326C (es)
CY (1) CY1123221T1 (es)
DK (1) DK3436074T3 (es)
EA (2) EA202091849A1 (es)
ES (1) ES2810303T3 (es)
HK (1) HK1250945A1 (es)
HR (1) HRP20201261T1 (es)
HU (1) HUE050601T2 (es)
IL (2) IL262018A (es)
LT (1) LT3436074T (es)
MX (1) MX2021004464A (es)
PH (1) PH12018502058A1 (es)
PL (1) PL3436074T3 (es)
PT (1) PT3436074T (es)
SG (1) SG11201808453UA (es)
SI (1) SI3436074T1 (es)
UA (1) UA126114C2 (es)
WO (1) WO2017173056A1 (es)
ZA (1) ZA201806644B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111012778B (zh) * 2018-10-10 2022-06-24 北京市农林科学院 Nitazoxanide在抑制犬细小病毒中的应用
CN109536460A (zh) * 2018-12-07 2019-03-29 中国医学科学院医学生物学研究所 一种cv-a10病毒毒种及其人用灭活疫苗
CN110787161B (zh) * 2019-09-19 2022-09-27 中山大学 噻唑类化合物用于抗鱼类病毒的新用途
CN111012788B (zh) * 2019-12-12 2021-01-15 武汉职业技术学院 硝唑尼特和替唑尼特在制备抗猪繁殖与呼吸综合征病毒药物中的应用
JP2023537237A (ja) 2020-07-20 2023-08-31 ロマーク ラボラトリーズ，リミティド カンパニー チゾキサニドおよび２－ヒドロキシ－ｎ－（５－クロロ－１，３－チアゾル－２－イル）ベンズアミド（ｒｍ－４８４８）とエタノールアミン、モルホリン、プロパノールアミン、ピペラジン、およびｎ－メチルピペラジンの結晶塩
CA3189487A1 (en) 2020-08-24 2023-03-03 Jean-Francois Rossignol Use of thiazolides against coronaviruses
CA3219500A1 (en) * 2021-05-28 2022-12-01 Theodore HENDERSON Treatment using an antiviral compound and nitazoxanide
TW202327621A (zh) 2021-09-15 2023-07-16 大陸商南京強新生物醫藥有限公司 治療冠狀病毒感染的新聯用藥物、藥物組合物及其用途
CN114404439B (zh) * 2022-02-11 2023-07-11 山东农业大学 抑制不同类型猪繁殖与呼吸综合症病毒感染的阻断剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US5387598A (en) 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
MX9604483A (es) 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
US5859038A (en) 1994-09-08 1999-01-12 Romark Laboratories, L.C. Method for treatment of helicobacter pylori infections
US5856348A (en) 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US5965590A (en) 1994-09-08 1999-10-12 Romark Lab Lc Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US5935591A (en) 1998-01-15 1999-08-10 Romark Laboratories, L.C. Method for treatment of equine protozoal myeloencephalitis with thiazolides
JP2007526208A (ja) 2003-04-11 2007-09-13 メディミューン，インコーポレーテッド 呼吸器の症状を治療又は予防する方法
UA90864C2 (en) 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US20060194853A1 (en) 2004-10-08 2006-08-31 Rossignol Jean F Alkyl benzamides
ES2422556T3 (es) 2006-01-09 2013-09-12 Romark Lab Lc Tratamiento de hepatitis vírica
CA2695517C (en) 2007-08-03 2016-09-20 J. Edward Semple Alkylsulfonyl-substituted thiazolide compounds
GB0716292D0 (en) * 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
BRPI1007945C8 (pt) 2009-02-13 2021-05-25 Romark Laboratories Lc formulação farmacêutica de liberação controlada de nitazoxanida, tizoxanida ou uma combinação dos mesmos, e, comprimido de bicamada para administração oral
CN105853415A (zh) 2009-05-12 2016-08-17 罗马克实验室有限公司 卤代烷基杂芳基苯甲酰胺化合物
JP5932640B2 (ja) 2009-06-26 2016-06-08 ロマーク ラボラトリーズ エル．シー． インフルエンザを治療するための化合物および方法
US8796273B2 (en) * 2010-06-25 2014-08-05 Biota Scientific Management Pty Ltd Compound for the treatment of enteroviruses
WO2012061190A1 (en) 2010-11-01 2012-05-10 Romark Laboratories L.C. Alkylsulfinyl-substituted thiazolide compounds
EA024063B1 (ru) 2011-05-16 2016-08-31 Ромарк Лабораториз Л.С. Способ стимуляции иммунного ответа путем введения тиазолидных соединений
WO2013136495A1 (ja) 2012-03-15 2013-09-19 トヨタ自動車株式会社 車両走行制御装置
TW201524990A (zh) * 2013-10-11 2015-07-01 Alios Biopharma Inc 經取代之核苷、核苷酸及其類似物
WO2016044656A1 (en) * 2014-09-17 2016-03-24 Ansun Biopharma, Inc. Treatment of infection by human enterovirus d68
AU2015346413B2 (en) 2014-11-11 2019-08-29 Romark Laboratories, L.C. Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof

Also Published As

Publication number Publication date
HRP20201261T1 (hr) 2021-02-05
JP6567781B2 (ja) 2019-08-28
PT3436074T (pt) 2020-08-21
IL262018A (en) 2018-10-31
US11135202B2 (en) 2021-10-05
KR20180124970A (ko) 2018-11-21
CY1123221T1 (el) 2021-10-29
CN108289961A (zh) 2018-07-17
CA3019326C (en) 2021-05-25
US20220125767A1 (en) 2022-04-28
SG11201808453UA (en) 2018-10-30
EA201891975A1 (ru) 2019-03-29
EP3436074A1 (en) 2019-02-06
JP2019510044A (ja) 2019-04-11
PL3436074T3 (pl) 2020-11-02
SI3436074T1 (sl) 2020-09-30
WO2017173056A1 (en) 2017-10-05
EP3677282A1 (en) 2020-07-08
KR102136803B1 (ko) 2020-07-22
PH12018502058A1 (en) 2019-06-24
US20170281603A1 (en) 2017-10-05
KR20210035339A (ko) 2021-03-31
KR102233826B1 (ko) 2021-03-31
UA126114C2 (uk) 2022-08-17
CA3113354A1 (en) 2017-10-05
EA202091849A1 (ru) 2020-12-11
EA036505B1 (ru) 2020-11-18
HUE050601T2 (hu) 2020-12-28
IL280327A (en) 2021-03-01
AU2017244145B2 (en) 2019-08-01
AU2019236602A1 (en) 2019-10-17
BR112018069974A2 (pt) 2019-01-29
EP3436074B1 (en) 2020-06-10
AU2017244145A1 (en) 2018-11-15
DK3436074T3 (da) 2020-08-03
ZA201806644B (en) 2021-02-24
KR20180125552A (ko) 2018-11-23
JP2019203014A (ja) 2019-11-28
LT3436074T (lt) 2020-09-25
CA3019326A1 (en) 2017-10-05
ES2810303T3 (es) 2021-03-08
HK1250945A1 (zh) 2019-01-18

Similar Documents

Publication Publication Date Title
MX2021004464A (es) Compuestos de tiazolida para el tratamiento de infecciones virales.
PH12016501254A1 (en) Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
MX2017008720A (es) Derivados y metodos para tratamiento de las infecciones por hepatitis b.
PH12016501379A1 (en) Azepane derivatives and methods of treating hepatitis b infections
HK1251219A1 (zh) 用於治療和預防乙型肝炎病毒感染的新的6，7-二氫吡啶並[2，1-a]酞嗪-2-酮類化合物
MX2018005569A (es) Vacunas contra el virus de la hepatitis b.
PH12017500207A1 (en) Indoles for use in influenza virus infection
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
EP3139954A4 (en) Methods and compositions for treating hepatitis b virus infections
EA030115B9 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
JOP20180008A1 (ar) مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b
CL2015003298A1 (es) Novedosas heteroarildihidropirimidinas unidas por puentes en 6 para el tratamiento y la profilaxis de infeccion por el virus de la hepatitis b
EA201690979A1 (ru) Производные азепана и способы лечения инфекций гепатита в
MX2017000312A (es) Derivados de isoindolina para usarse en el tratamiento de una infeccion viral.
MX2017005249A (es) Compuestos para usarse en el tratamiento antihelmintico.
BR112016023833A2 (pt) compostos, composições, métodos e uso para tratar ou prevenir infecções por vírus da hepatite c
PH12017500816A1 (en) Long acting pharmaceutical compositions for hepatitis c
MX2017001047A (es) Compuestos para usar en el tratamiento antihelmintico.
PH12017500820A1 (en) Combination long acting compositions and methods for hepatitis c
MX2016012104A (es) Compuestos de azabenzofurano que contienen ciano para el tratamiento de la hepatitis c.
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
HK1210057A1 (en) Azetidinone compound used for prevention and or treatment of hepatitis c, and composition of the compound
TR201910305T4 (tr) Viral enfeksiyonları tedavi etmek için bileşikler.
WO2015051268A3 (en) Hiv protease inhibitors against picornavirus infection